Posts

Sunday Surprises

By at

Patenting stem cell therapies in the US: The role and risks of product-by-process claims (Restem v Jadi cell)

By at

Is AI software for IP just expensive wrapping paper?

By at

MAN v Rolls-Royce – How not to advertise your mark

By at

AG Emiliou advises CJEU to rule that OCSSPs' authorization under Article 17 of the DSM Directive extends to acts of reproduction

By at

[Guest post] Wear your trade mark on your sleeve: sponsorship agreements and termination clauses in the football industry

By at

The CIPA Black Book needs you!

By at

Never Too Late: If you missed the IPKat last week!

By Kliment Markov at

[GuestPost] Creation, grief, guilt, and love

By at

GuestPost: The USPTO’s Climate Change Mitigation Pilot: End of a green fast-track and what it means

By at

Australia's extension of time provisions for patents have their limits (and may soon have more)

By at

EU and Australia finally reach compromise on Prosecco GI

By at